Hall Ashley 4
4 · Structure Therapeutics Inc. · Filed Mar 5, 2026
Insider Transaction Report
Form 4
Hall Ashley
Chief Development Officer
Transactions
- Tax Payment
Ordinary Shares
[F1][F2]2026-03-03$20.99/sh−4,836$101,508→ 107,481 total - Award
American Depositary Shares
[F3][F4][F1]2025-05-20+225→ 225 total→ Ordinary Shares (675 underlying) - Award
American Depositary Shares
[F3][F5][F1]2025-11-20+237→ 462 total→ Ordinary Shares (711 underlying)
Footnotes (5)
- [F1]The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.
- [F2]Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award.
- [F3]Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.
- [F4]Voluntary reporting of the acquisition of 225 ADSs by the Reporting Person on May 20, 2025 pursuant to the Issuer's Employee Share Purchase Plan.
- [F5]Voluntary reporting of the acquisition of 237 ADSs by the Reporting Person on November 20, 2025 pursuant to the Issuer's Employee Share Purchase Plan.
Signature
/s/ Jun Yoon, Attorney-in-Fact|2026-03-05